Evidence map›Paper›PMID 30001105›Full record

ReviewACS chemical neuroscience2019

Use and Future Prospects of in Vivo Microdialysis for Epilepsy Studies.

Alexander G Zestos, Hiram Luna-Munguia, William C Stacey, Robert T Kennedy

Open access · greenAbstract readReview
In one paragraph

Review in ACS chemical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Anti-seizure effects of WS-3, a TRPM8 agonist, on focal onset seizure mouse model via reduction of extracellular glutamate levels.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  2. A Poly(methacrolein-Nanomaterials (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Alexander G ZestosDepartment of Chemistry, Center for Behavioral Neuroscience , American University , Washington, D.C. 20016 , United States.ORCID 0000-0002-4804-4278
Hiram Luna-MunguiaDepartamento de Neurobiologia Conductual y Cognitiva, Instituto de Neurobiologia , Universidad Nacional Autonoma de Mexico, Campus UNAM-Juriquilla , Queretaro 76230 , Mexico.
William C StaceyDepartment of Biomedical Engineering , University of Michigan , Ann Arbor , Michigan 48109 , United States.
Robert T KennedyDepartment of Chemistry , University of Michigan , Ann Arbor , Michigan 48109 , United States.ORCID 0000-0003-2447-7471
University of Michigan · USAmerican University · USUniversidad Nacional Autónoma de México · MX

Funding

POSTDOCTORAL TRAINING IN THE BIOLOGY OF DRUG ABUSET32DA007268 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1991 to 2021
$6.7M
Characterizing High Frequency Oscillations as an epilepsy biomarker with Big Data toolsR01NS094399 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STACEY, WILLIAM CHARLES · 2015 to 2025
$4.1M
In vivo chemical monitoring using capillary separationsR01EB003320 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2003 to 2020
$2.7M
NIBIB NIH HHS R01 EB003320NIDA NIH HHS T32 DA007268NINDS NIH HHS R01 NS094399
6 · The paper itself

Abstract

Epilepsy is a common neurological disease characterized by recurrent unpredictable seizures. For the last 30 years, microdialysis sampling has been used to measure changes in excitatory and inhibitory neurotransmitter concentrations before, during, and after seizures. These advances have fostered breakthroughs in epilepsy research by identifying neurochemical changes associated with seizures and correlating them to electrophysiological data. Recent advances in methodology may be useful in further delineating the chemical underpinnings of seizures. A new model of ictogenesis has been developed that allows greater control over the timing of seizures that are similar to spontaneous seizures. This model will facilitate making chemical measurements before and during a seizure. Recent advancements in microdialysis sampling, including the use of segmented flow, "fast" liquid chromatography (LC), and capillary electrophoresis with laser-induced fluorescence (CE-LIF) have significantly improved temporal resolution to better than 1 min, which could be used to measure transient, spontaneous neurochemical changes associated with seizures. Microfabricated sampling probes that are markedly smaller than conventional probes and allow for a much greater spatial resolution have been developed. They may allow the targeting of specific brain regions important to epilepsy studies. Coupling microdialysis sampling to optogenetics and light-stimulated release of neurotransmitters may also prove useful for studying epileptic seizures.

Indexed as

AnimalsBrainChromatography, LiquidElectrophoresis, CapillaryEpilepsyForecastinggamma-Aminobutyric AcidGlutamic AcidHistamineHumansMicrodialysisNeurotransmitter AgentsSpectrometry, Fluorescencegamma-Aminobutyric AcidGlutamic AcidHistamineNeurotransmitter AgentsCE-LIFepilepsyLC-MSMicrodialysisseizurestemporal resolution

Identifiers

PMID30001105
PMCPMC6524784
OpenAlexW2814272055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.